Coronary Physiology after Aortic Valve Intervention

Impact of Aortic Valve Intervention on Coronary Flow Reserve


Myocardial flow might be compromised in patients with severe aortic stenosis, which might be driven by CAD and concomitant atherosclerosis or a compromised capillary bed. Capillary circulation might be compromised by increased left ventricular mass (LVM) which in turn might alter coronary flow reserve (CFR). 

Fisiología coronaria posterior a la intervención en la válvula aórtica

Multiple studies have shown images of LMV regression after adequate aortic valve intervention. However, the physiological impact of aortic valve intervention on coronary circulation remains unclear. 

The aim of this study by Sabbah M, et al. was to look into the impact of TAVR or SAVR (transcatheter or surgical valve replacement) in CFR and to determine whether these changes are related to a difference in LV stroke work (LVSW, mean transvalvular gradient and LV stroke volume).  

This was a prospective, observational study carried out in two Danish centers. It excluded patients with ventricular function ≤45%, glomerular filtration ≤30ml/min, patients presenting associated coronary lesions, and patients with other moderate/severe valvulopathies. Coronary angiograms were done to measure CFR as well as cardiac MRI prior intervention and 6 months after. 

Read also: Rivaroxaban in Acute Coronary Syndrome.

The study looked at the anterior descending only and assessed indexes included CFR, microcirculation resistance index (MRi) with PressureWire X, hyperemia coronary flow (QLAD) and microvascular minimal resistance (Rμ,LAD) with infusion catheter RayFlow. Mean transit time (MTT) was used as surrogate measurement of volumetric flow. 

34 patients were analyzed, mean age 72±8, 71% trivalves, 50% received TAVR, 41% SAVR with bioprosthesis and 9% SAVR with mechanical valve. 50% of patients did not present ventricular hypertrophy when measured with MR. 

At followup, there was mean reduction of 18.5g/m2 (Δ20%) on mass ventricular index (p≤0.001) confirmed by MR, LVSW was reduced from 20.8 to 17.9 cJ (p=0.04). Fractional flow reserve (FFR), IMR, QLAD and Rμ,LAD saw no significant change at followup. 

Read also: Relationship Between Medical Treatment and Long-Term Clinical Results after Peripheral Vascular Intervention.

CFR improved significantly in 71% of patients (82% of TAVR patients and 59% SAVR), with no significant changes in hyperemic flow (QLAD; 230±106mL/min to 250±101mL/min; p=0.26) or minimal microvascular resistance (Rμ,LAD; 347 [247-463] to 287 [230-456]; p=0.20). Resting MTT was higher while hyperemic MTT saw no change.   

Conclusions

This study looked at the long term effects on left anterior descending physiology after TAVR or SAVR intervention. CFR increased significantly with no change in QLAD or Rμ,LAD and this increase was mainly associated to LVSW  reduction.

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original Title: Long-term changes in coronary physiology after aortic valve replacement.

Reference: Sabbah M, Olsen NT, Holmvang L, et al. Long-term changes in coronary physiology after aortic valve replacement [published online ahead of print, 2022 Oct 13]. EuroIntervention. 2022;18(14):1156-1164. doi:10.4244/EIJ-D-22-00621.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

TCT 2024 – EVOLVED trial: Early Intervention for Patients with Severe Asymptomatic Aortic Stenosis and Myocardial Fibrosis?

Treating symptomatic severe aortic stenosis (AS) with aortic valve replacement is currently considered a class I recommendation, evidence level B, according to the current...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...